Epidemiology of chronic Pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis

Thorax

Volumn 52, Issue 4, 1997, Pages 318-321

  Walter, Siegbert ^a,b   Gudowius, Peter ^b   Boßhammer, Jutta ^b   Römling, Ute ^b,c   Weißbrodt, Hartmut ^b   Schürmann, Wolfgang ^b   Von Der Hardt, Horst ^b   Tümmler, Burkhard ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cystic fibrosis; Lung transplantation; Pseudomonas aeruginosa

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; FEMALE; HUMAN; LUNG TRANSPLANTATION; MALE; OPPORTUNISTIC INFECTION; PARANASAL SINUS; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TRACHEA;

EID: 0030974760     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.4.318     Document Type: Article

References (25)

1. Tsang V, Hodson ME, Yacoub MH. Lung transplantation for cystic fibrosis. Br Med Bull 1992;48:949-71.
2. Wood A, Higenbottam T, Jackson M, Scott J, Stewart S, Wallwork J. Airway mucosal bioelectric potential difference in cystic fibrosis after lung transplantation. Am Rev Respir Dis 1989;140:1645-9.
3. Knowles MR, Stutts MJ, Spock A, Fisher N, Gatzy JT, Boucher RC. Abnormal permeation through cystic fibrosis respiratory epithelium. Science 1983;221:1067-70.
4. Taylor CJ, McGaw J, Howden R, Duerden BI, Baxter PS. Bacterial reservoirs in cystic fibrosis. Arch Dis Child 1990; 65:175-7.
5. Tsang V, Pitt TL, Kaufmann ME, Gaya H, Hodson ME, Yacoub M. Colonisation of lung allografts with Pseudomonas aeruginosa in heart-lung transplant recipients with cystic fibrosis. Thorax 1994;49:721-2.
6. Steinbach S, Sun L, Jiang RZ, Flume P, Gilligan P, Egan TM, et al. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung transplant recipients with cystic fibrosis. N Engl J Med 1994;331:981-7.
7. Thorpe JE, Baugham RP, Frame PT, Wesseler TA, Staneck JL. Bronchoalveolar lavage for diagnosing acute bacterial pneumonia. J Infect Dis 1987;155:855-61.
8. Kahn FW, Jones JM. Diagnosing bacterial respiratory infection by bronchoalveolar lavage. J Infect Dis 1987;155: 862-9.
9. Lode H, Schaberg T, Raffenberg M, Mauch H. Diagnostic problems in lower respiratory tract infections. J Antimicrob Chemother 1993;32:29-37.
10. Römling U, Fiedler B, Bosshammer J, Grothues D, Greipel J, von der Hardt H, et al. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J Infect Dis 1994;170:1616-21.
11. Schmidt KD, Tümmler B, Römling U. Comparative genome mapping of Pseudomonas aeroginosa PAO with P aeruginosa C, which belongs to a major clone in cystic fibrosis patients and aquatic habitats. J Bacteriol 1996;178:85-93.
12. Sundaresan S, Trulock EP, Mohanakumar T, Cooper JD, Patterson GA, and the Washington Lung Transplant Group. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Ann Thorac Surg 1995;60:1341-7.
13. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993;12:713-6.
14. Madden BP, Hodson ME, Tsang V, Radley-Smith R, Khaghani A, Yacoub MY. Intermediate-term results of heart-lung transplantation for cystic fibrosis. Lancet 1992; 339:1583-7.
15. Ogle JW, Janda JM, Woods DE, Vasil ML. Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa. J Infect Dis 1987;155:119-26.
16. Pritchard AE, Vasil ML. Possible insertion sequences in a mosaic genome organization upstream of the exotoxin A gene in Pseudomonas aeruginosa. J Bacteriol 1990;172: 2020-8.
17. Sokol PA, Luan MZ, Storey DG, Thirukkumaran P. Genetic rearrangement associated with in vivo mucoid conversion of Pseudomonas aeruginosa PAO is due to insertion elements. J Bacteriol 1994;176:553-62.
18. Shankar S, Fulsham L, Read R, Theodoroupoulos S, Cole P, Madden B, et al. Mucociliary function after lung transplantation. Transplant Proc 1991;23:1222-3.
19. Umetsu DT, Moss RB, King VV, Lewiston NJ. Sinus disease in patients with severe cystic fibrosis: relation to pulmonary exacerbation. Lancet 1990;335:1077-8.
20. Lewiston N, King V, Umetsu D, Starnes V, Marshall S, Kramer At, et al. Cystic fibrosis patients who have undergone heart-lung transplantation benefit from maxillary sinus antrostomy and repeated sinus lavage. Transplant Proc 1991;23:1207-8.
21. Moss RB, King VV. Management of sinusitis in cystic fibrosis by endoscopie surgery and serial antimicrobial lavage. Arch Otolaryngol Head Neck Surg 1995;121:566-72.
22. Davidson TM, Murphy C, Mitchell M, Smith C, Light M. Management of chronic sinusitis in cystic fibrosis. Laryngoscope 1995;105:354-8.
23. Madden BP, Kamalvand K, Chan CM, Khaghani A, Hodson ME, Yacoub M. The medical management of patients with cystic fibrosis following heart-lung transplantation. Eur Respir J 1993;6:965-70.
24. Flume PA, Egan TM, Paradowski LJ, Detterbeck FC, Thompson JT, Yankaskas JR. Infectious complications of lung transplantation: impact of cystic fibrosis. Am J Respir Crit Care Med 1994;149:1601-7.
25. Stammberger H, Wolf G. Headaches and sinus disease: the endoscopic approach. Ann Otol Rhinol Laryngol 1988;97: 3-23.